MedTrace Logo

The Study to Evaluate the Safety and Efficacy of the Onyx Family

NCT06577896 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2024-09-19

No results posted yet for this study

Summary

Observation of the safety and efficacy of 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention using Onyx family stents in elderly patients aged 75 years or older

Conditions

Interventions

DEVICE

Onyx family

Safety and Efficacy of 1-Month DAPT in Elderly Patients at High Risk of Ischemia and Bleeding After Percutaneous Coronary Intervention with Onyx Family Stents

Sponsors & Collaborators

  • Pusan National University Yangsan Hospital

    lead OTHER

Principal Investigators

  • Min Ku Chon, MD,PhD · Pusan National University Yangsan Hospital

Eligibility

Min Age
75 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-09
Primary Completion
2026-01-31
Completion
2026-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577896 on ClinicalTrials.gov